Two drug makers sanctioned for non-obligation of GMP standards
Published: 2011-03-08 06:56:00
Updated: 2011-03-08 06:56:00
The Korea Food and Drug Administration says it notified MSD Korea and GSK to have two companies suspend the importation of Cozaar Plus-F tablets and Lamictal tablets, respectively, for one month (from May 14 to April 13) due to local distribution of substandard products.
The administration add...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.